A Study of Human Allogeneic Bone-marrow-derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Aging Frailty
Clinical trial NCT06070532 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06070532
- Sponsor
- Cellcolabs Clinical LTD.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2026-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.